 |
市場調査レポート
商品コード
1233234
全ゲノムシーケンス市場規模、シェア、動向分析レポート製品別（装置、消耗品、サービス）、タイプ別、ワークフロー別、用途別、最終用途別、地域別、セグメント別予測、2023年～2030年Whole Genome Sequencing Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables, Services), By Type, By Workflow, By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。 詳細はお問い合わせください。
価格
| 全ゲノムシーケンス市場規模、シェア、動向分析レポート製品別（装置、消耗品、サービス）、タイプ別、ワークフロー別、用途別、最終用途別、地域別、セグメント別予測、2023年～2030年 |
|
出版日: 2023年02月23日
発行: Grand View Research
ページ情報: 英文 180 Pages
納期: 2～10営業日
|
- 全表示
- 概要
- 図表
- 目次
概要
全ゲノムシーケンス市場の成長と動向
Grand View Research, Inc.の新しいレポートによると、全ゲノムシーケンスの世界市場規模は、2023年から2030年にかけて20.06%のCAGRで拡大し、2030年までに66億7000万米ドルに達すると予測されます。
この市場成長の背景には、ゲノムマッピングプログラムへの全ゲノムシーケンスの採用が増加していること、および希少遺伝性疾患を含む遺伝性疾患の有病率が上昇していることが挙げられます。2021年11月にNew England Journal of Medicineに掲載された研究によると、全ゲノム配列決定により、幅広い希少疾患の早期診断が可能になり、精密医療への移行が報告されています。
さらに、WGSを用いた疾患の早期発見・治療のための研究開発への投資が増加していることも、市場の成長を促進すると予想されます。例えば、2023年2月、インドネシア政府とゲノム科学イニシアティブは、世界基金から3000万米ドルの投資を受け、COVID-19、結核、がん、遺伝病、脳疾患、代謝障害などの障害の早期発見と治療のための方法を実施する施設のネットワークを設立しました。
ホールゲノムシークエンスは幅広い応用が可能であり、政府機関がヒト、植物、動物、微生物のゲノムを解読するためにこれらの技術を採用していることから、市場の成長を促進すると期待されています。例えば、米国食品医薬品局（FDA）は、各国で食中毒が発生した際に、食中毒病原体を特定するためにこの方法を採用しました。FDAは、全ゲノムシーケンス（WGS）プログラムのもと、2008年からこの技術を採用しており、パルスフィールドゲル電気泳動（PFGE）よりも効率的に食中毒病原体の全株を識別することができるためです。
技術の進歩に伴い、様々な疾患や感染症を手頃な価格で正確かつタイムリーに診断できる革新的な全ゲノムシーケンス製品が発売されるようになりました。これが市場の成長に寄与しています。例えば、2022年12月、LifeCell International Pvt. Ltd.はHaystackAnalyticsと共同で、結核感染症の診断情報を特定し、薬剤耐性課題に取り組むための全ゲノムシーケンス検査「TB」を発売しています。
COVID-19の大流行により、この手法に対する需要が世界的に高まり、SARS-CoV-2の迅速な特定と、大流行を管理するための可能な診断テストの開発が可能となっています。そのため、世界中の政府が研究機関や企業と協力し、SARS-CoV-2の特定と診断のためにこの方法を使用しました。いくつかの企業が、SARS-CoV-2ウイルスの監視のためのゲノムサービスや迅速なソリューションを発表しています。例えば、QIAGENは、強力な変異体の特定、起こりうるアウトブレイクの追跡、ワクチン研究と医薬品開発の進展のための全ゲノムシーケンスサービスSARS-CoV-2監視を提供しています。
全ゲノムシーケンス市場レポートハイライト
- 消耗品セグメントは、幅広い種類の消耗品が利用可能であり、これらの製品の使用期間が短いため採用が増加していることから、2022年には61.56%の最大シェアを占めました。
- タイプ別では、大型全ゲノムシーケンスセグメントが2022年の全ゲノムシーケンス市場において77.32%の最大シェアを占めました。これは、がん腫瘍の解析や希少疾患の遺伝子変異の特定などの用途が拡大していることに起因していると考えられます。
- ワークフロー別では、シーケンシングセグメントが2022年に52.12%の最大市場シェアを占めましたが、これは大手企業の関与が高まり、プロセスの採用を後押しする新規製品が発売されたためです。
- アプリケーション別では、ヒト全ゲノムシーケンスセグメントが2022年に62.91%のシェアを獲得し、市場を独占しました。これは、希少な遺伝性疾患の有病率の増加や、これらの疾患の原因物質を特定するための研究開発への投資が増加していることに起因していると思われます。
- 最終用途別では、学術・研究機関分野が48.72%の最大シェアで世界市場を独占しています。このセグメントの大きなシェアは、この分野の包括的な研究を行うために、これらの施設でハイスループット技術への需要が高まっていることに起因しています。
- 北米は、2022年に51.34%の最大シェアを占めました。この大きなシェアは、この地域に確立されたヘルスケアシステムと製薬業界が存在し、臨床および研究目的での全ゲノムシーケンスの大きな需要を生み出していることに起因していると考えられます。
目次
第1章 調査手法と範囲
- 情報調達
- 情報またはデータ分析
- 市場範囲とセグメントの定義
- 市場モデル
- 市場調査、企業の市場シェア別
- 地域分析
第2章 エグゼクティブサマリー
- 市場のスナップショット
- セグメントのスナップショット
- 競合情勢のスナップショット
第3章 市場変数、動向、および範囲
- 市場セグメンテーションと範囲
- 市場系列の見通し
- 親市場の見通し
- 関連/補助的な市場の見通し
- 市場力学
- 遺伝性疾患の有病率の上昇
- 遺伝子配列決定のコスト削減
- ゲノムマッピングプログラムのための全ゲノムシーケンスに対する需要の高まり
- 市場抑制要因分析
- ゲノム配列決定に関連する倫理的および法的課題
- 業界分析ツール
- ポーターのファイブフォース分析
- マクロ経済分析
- COVID-19影響分析
第4章 全ゲノムシーケンシング市場：製品ビジネス分析
- 全ゲノムシーケンシング市場：製品市場シェア分析
- 全ゲノムシーケンシング市場の推定・予測、製品別（USD Million）
- 機器
- 消耗品
- サービス
第5章 全ゲノムシーケンシング市場：タイプビジネス分析
- 全ゲノムシーケンシング市場：タイプ市場シェア分析
- タイプ別の全ゲノムシーケンシング市場の推定・予測（百万米ドル）
- 大規模全ゲノムシーケンス
- 小さな全ゲノムシーケンス
第6章 全ゲノムシーケンシング市場：ワークフロービジネス分析
- 全ゲノムシーケンシング市場：ワークフロー市場シェア分析
- 全ゲノムシーケンシング市場の推定・予測、ワークフロー別（USD Million）
- プレシーケンス
- シーケンシング
- データ分析
第7章 全ゲノムシーケンシング市場：アプリケーションビジネス分析
- 全ゲノムシーケンシング市場：アプリケーション市場シェア分析
- アプリケーション別の全ゲノムシーケンシング市場の推定・予測（百万米ドル）
- ヒト全ゲノムシーケンシング
- 植物全体のエクソームシーケンス
- 動物全体のエクソームシーケンス
- 微生物の全エクソームシーケンス
第8章 全ゲノムシーケンシング市場：エンドユースビジネス分析
- 全ゲノムシーケンシング市場：エンドユース市場シェア分析
- 全ゲノムシーケンシング市場の推定・予測、最終用途別（100万米ドル）
- 学術・調査機関
- 病院と診療所
- 製薬およびバイオテクノロジー企業
- その他
第9章 全ゲノムシーケンシング市場：地域ビジネス分析
- 地域別全ゲノムシーケンシング市場シェア、2022年および2030年
- 北米
- 米国
- 主要な国のダイナミクス
- 対象疾患の有病率
- 競合シナリオ
- 規制の枠組み
- 償還シナリオ
- カナダ
- 主要な国のダイナミクス
- 対象疾患の有病率
- 競合シナリオ
- 規制の枠組み
- 償還シナリオ
- 米国
- 欧州
- ドイツ
- 主要な国のダイナミクス
- 対象疾患の有病率
- 競合シナリオ
- 規制の枠組み
- 償還シナリオ
- 英国
- 主要な国のダイナミクス
- 対象疾患の有病率
- 競合シナリオ
- 規制の枠組み
- 償還シナリオ
- フランス
- 主要な国のダイナミクス
- 対象疾患の有病率
- 競合シナリオ
- 規制の枠組み
- 償還シナリオ
- イタリア
- 主要な国のダイナミクス
- 対象疾患の有病率
- 競合シナリオ
- 規制の枠組み
- 償還シナリオ
- スペイン
- 主要な国のダイナミクス
- 対象疾患の有病率
- 競合シナリオ
- 規制の枠組み
- 償還シナリオ
- デンマーク
- 主要な国のダイナミクス
- 対象疾患の有病率
- 競合シナリオ
- 規制の枠組み
- 償還シナリオ
- スウェーデン
- 主要な国のダイナミクス
- 対象疾患の有病率
- 競合シナリオ
- 規制の枠組み
- 償還シナリオ
- ノルウェー
- 主要な国のダイナミクス
- 対象疾患の有病率
- 競合シナリオ
- 規制の枠組み
- 償還シナリオ
- ドイツ
- アジア太平洋地域
- 日本
- 主要な国のダイナミクス
- 対象疾患の有病率
- 競合シナリオ
- 規制の枠組み
- 償還シナリオ
- 中国
- 主要な国のダイナミクス
- 対象疾患の有病率
- 競合シナリオ
- 規制の枠組み
- 償還シナリオ
- インド
- 主要な国のダイナミクス
- 対象疾患の有病率
- 競合シナリオ
- 規制の枠組み
- 償還シナリオ
- 韓国
- 主要な国のダイナミクス
- 対象疾患の有病率
- 競合シナリオ
- 規制の枠組み
- 償還シナリオ
- オーストラリア
- 主要な国のダイナミクス
- 対象疾患の有病率
- 競合シナリオ
- 規制の枠組み
- 償還シナリオ
- タイ
- 主要な国のダイナミクス
- 対象疾患の有病率
- 競合シナリオ
- 規制の枠組み
- 償還シナリオ
- 日本
- ラテンアメリカ
- ブラジル
- 主要な国のダイナミクス
- 対象疾患の有病率
- 競合シナリオ
- 規制の枠組み
- 償還シナリオ
- メキシコ
- 主要な国のダイナミクス
- 対象疾患の有病率
- 競合シナリオ
- 規制の枠組み
- 償還シナリオ
- アルゼンチン
- 主要な国のダイナミクス
- 対象疾患の有病率
- 競合シナリオ
- 規制の枠組み
- 償還シナリオ
- ブラジル
- MEA
- 南アフリカ
- 主要な国のダイナミクス
- 対象疾患の有病率
- 競合シナリオ
- 規制の枠組み
- 償還シナリオ
- サウジアラビア
- 主要な国のダイナミクス
- 対象疾患の有病率
- 競合シナリオ
- 規制の枠組み
- 償還シナリオ
- アラブ首長国連邦
- 主要な国のダイナミクス
- 対象疾患の有病率
- 競合シナリオ
- 規制の枠組み
- 償還シナリオ
- クウェート
- 主要な国のダイナミクス
- 対象疾患の有病率
- 競合シナリオ
- 規制の枠組み
- 償還シナリオ
- 南アフリカ
第10章 競合情勢
- 企業分類
- 市場企業のシェア分析, 2022
- 戦略マッピング
- 企業プロファイル/リスト
- Illumina, Inc.
- Overview
- Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- Product Benchmarking
- Strategic Initiatives
- Thermo Fisher Scientific, Inc.
- Overview
- Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- Product Benchmarking
- Strategic Initiatives
- Oxford Nanopore Technologies
- Overview
- Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- Product Benchmarking
- Strategic Initiatives
- Pacific Biosciences of California, Inc.
- Overview
- Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- Product Benchmarking
- Strategic Initiatives
- BGI
- Overview
- Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- Product Benchmarking
- Strategic Initiatives
- QIAGEN
- Overview
- Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- Product Benchmarking
- Strategic Initiatives
- Agilent Technologies
- Overview
- Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- Product Benchmarking
- Strategic Initiatives
- ProPhase Labs, Inc. (Nebula Genomics)
- Overview
- Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- Product Benchmarking
- Strategic Initiatives
- Psomagen
- Overview
- Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- Product Benchmarking
- Strategic Initiatives
- Azenta US, Inc. (GENEWIZ)
- Overview
- Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- Product Benchmarking
- Strategic Initiatives
- Illumina, Inc.
図表
List of Tables
- Table 1 List of secondary sources
- Table 2 List of abbreviations
- Table 3 Global whole genome sequencing market, by product, 2018 - 2030 (USD Million)
- Table 4 Global whole genome sequencing market, by type, 2018 - 2030 (USD Million)
- Table 5 Global whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
- Table 6 Global whole genome sequencing market, by application, 2018 - 2030 (USD Million)
- Table 7 Global whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
- Table 8 Global whole genome sequencing market, by region, 2018 - 2030 (USD Million)
- Table 9 North America whole genome sequencing market, by country, 2018 - 2030 (USD Million)
- Table 10 North America whole genome sequencing market, by product, 2018 - 2030 (USD Million)
- Table 11 North America whole genome sequencing market, by type, 2018 - 2030 (USD Million)
- Table 12 North America whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
- Table 13 North America whole genome sequencing market, by application, 2018 - 2030 (USD Million)
- Table 14 North America whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
- Table 15 U.S. whole genome sequencing market, by product, 2018 - 2030 (USD Million)
- Table 16 U.S. whole genome sequencing market, by type, 2018 - 2030 (USD Million)
- Table 17 U.S. whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
- Table 18 U.S. whole genome sequencing market, by application, 2018 - 2030 (USD Million)
- Table 19 U.S. whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
- Table 20 Canada whole genome sequencing market, by product, 2018 - 2030 (USD Million)
- Table 21 Canada whole genome sequencing market, by type, 2018 - 2030 (USD Million)
- Table 22 Canada whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
- Table 23 Canada whole genome sequencing market, by application, 2018 - 2030 (USD Million)
- Table 24 Canada whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
- Table 25 Europe whole genome sequencing market, by country, 2018 - 2030 (USD Million)
- Table 26 Europe whole genome sequencing market, by product, 2018 - 2030 (USD Million)
- Table 27 Europe whole genome sequencing market, by type, 2018 - 2030 (USD Million)
- Table 28 Europe whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
- Table 29 Europe whole genome sequencing market, by application, 2018 - 2030 (USD Million)
- Table 30 Europe whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
- Table 31 U.K. whole genome sequencing market, by product, 2018 - 2030 (USD Million)
- Table 32 U.K. whole genome sequencing market, by type, 2018 - 2030 (USD Million)
- Table 33 U.K. whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
- Table 34 U.K. whole genome sequencing market, by application, 2018 - 2030 (USD Million)
- Table 35 U.K. whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
- Table 36 Germany whole genome sequencing market, by product, 2018 - 2030 (USD Million)
- Table 37 Germany whole genome sequencing market, by type, 2018 - 2030 (USD Million)
- Table 38 Germany whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
- Table 39 Germany whole genome sequencing market, by application, 2018 - 2030 (USD Million)
- Table 40 Germany whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
- Table 41 France whole genome sequencing market, by product, 2018 - 2030 (USD Million)
- Table 42 France whole genome sequencing market, by type, 2018 - 2030 (USD Million)
- Table 43 France whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
- Table 44 France whole genome sequencing market, by application, 2018 - 2030 (USD Million)
- Table 45 France whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
- Table 46 Italy whole genome sequencing market, by product, 2018 - 2030 (USD Million)
- Table 47 Italy whole genome sequencing market, by type, 2018 - 2030 (USD Million)
- Table 48 Italy whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
- Table 49 Italy whole genome sequencing market, by application, 2018 - 2030 (USD Million)
- Table 50 Italy whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
- Table 51 Spain whole genome sequencing market, by product, 2018 - 2030 (USD Million)
- Table 52 Spain whole genome sequencing market, by type, 2018 - 2030 (USD Million)
- Table 53 Spain whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
- Table 54 Spain whole genome sequencing market, by application, 2018 - 2030 (USD Million)
- Table 55 Spain whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
- Table 56 Denmark whole genome sequencing market, by product, 2018 - 2030 (USD Million)
- Table 57 Denmark whole genome sequencing market, by type, 2018 - 2030 (USD Million)
- Table 58 Denmark whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
- Table 59 Denmark whole genome sequencing market, by application, 2018 - 2030 (USD Million)
- Table 60 Denmark whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
- Table 61 Sweden whole genome sequencing market, by product, 2018 - 2030 (USD Million)
- Table 62 Sweden whole genome sequencing market, by type, 2018 - 2030 (USD Million)
- Table 63 Sweden whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
- Table 64 Sweden whole genome sequencing market, by application, 2018 - 2030 (USD Million)
- Table 65 Sweden whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
- Table 66 Norway whole genome sequencing market, by product, 2018 - 2030 (USD Million)
- Table 67 Norway whole genome sequencing market, by type, 2018 - 2030 (USD Million)
- Table 68 Norway whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
- Table 69 Norway whole genome sequencing market, by application, 2018 - 2030 (USD Million)
- Table 70 Norway whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
- Table 71 Asia Pacific whole genome sequencing market, by country, 2018 - 2030 (USD Million)
- Table 72 Asia Pacific whole genome sequencing market, by product, 2018 - 2030 (USD Million)
- Table 73 Asia Pacific whole genome sequencing market, by type, 2018 - 2030 (USD Million)
- Table 74 Asia Pacific whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
- Table 75 Asia Pacific whole genome sequencing market, by application, 2018 - 2030 (USD Million)
- Table 76 Asia Pacific whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
- Table 77 Japan whole genome sequencing market, by product, 2018 - 2030 (USD Million)
- Table 78 Japan whole genome sequencing market, by type, 2018 - 2030 (USD Million)
- Table 79 Japan whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
- Table 80 Japan whole genome sequencing market, by application, 2018 - 2030 (USD Million)
- Table 81 Japan whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
- Table 82 China whole genome sequencing market, by product, 2018 - 2030 (USD Million)
- Table 83 China whole genome sequencing market, by type, 2018 - 2030 (USD Million)
- Table 84 China whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
- Table 85 China whole genome sequencing market, by application, 2018 - 2030 (USD Million)
- Table 86 China whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
- Table 87 India whole genome sequencing market, by product, 2018 - 2030 (USD Million)
- Table 88 India whole genome sequencing market, by type, 2018 - 2030 (USD Million)
- Table 89 India whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
- Table 90 India whole genome sequencing market, by application, 2018 - 2030 (USD Million)
- Table 91 India whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
- Table 92 Australia whole genome sequencing market, by product, 2018 - 2030 (USD Million)
- Table 93 Australia whole genome sequencing market, by type, 2018 - 2030 (USD Million)
- Table 94 Australia whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
- Table 95 Australia whole genome sequencing market, by application, 2018 - 2030 (USD Million)
- Table 96 Australia whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
- Table 97 Thailand whole genome sequencing market, by product, 2018 - 2030 (USD Million)
- Table 98 Thailand whole genome sequencing market, by type, 2018 - 2030 (USD Million)
- Table 99 Thailand whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
- Table 100 Thailand whole genome sequencing market, by application, 2018 - 2030 (USD Million)
- Table 101 Thailand whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
- Table 102 South Korea whole genome sequencing market, by product, 2018 - 2030 (USD Million)
- Table 103 South Korea whole genome sequencing market, by type, 2018 - 2030 (USD Million)
- Table 104 South Korea whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
- Table 105 South Korea whole genome sequencing market, by application, 2018 - 2030 (USD Million)
- Table 106 South Korea whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
- Table 107 Latin America whole genome sequencing market, by country, 2018 - 2030 (USD Million)
- Table 108 Latin America whole genome sequencing market, by product, 2018 - 2030 (USD Million)
- Table 109 Latin America whole genome sequencing market, by type, 2018 - 2030 (USD Million)
- Table 110 Latin America whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
- Table 111 Latin America whole genome sequencing market, by application, 2018 - 2030 (USD Million)
- Table 112 Latin America whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
- Table 113 Brazil whole genome sequencing market, by product, 2018 - 2030 (USD Million)
- Table 114 Brazil whole genome sequencing market, by type, 2018 - 2030 (USD Million)
- Table 115 Brazil whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
- Table 116 Brazil whole genome sequencing market, by application, 2018 - 2030 (USD Million)
- Table 117 Brazil whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
- Table 118 Mexico whole genome sequencing market, by product, 2018 - 2030 (USD Million)
- Table 119 Mexico whole genome sequencing market, by type, 2018 - 2030 (USD Million)
- Table 120 Mexico whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
- Table 121 Mexico whole genome sequencing market, by application, 2018 - 2030 (USD Million)
- Table 122 Mexico whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
- Table 123 Argentina whole genome sequencing market, by product, 2018 - 2030 (USD Million)
- Table 124 Argentina whole genome sequencing market, by type, 2018 - 2030 (USD Million)
- Table 125 Argentina whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
- Table 126 Argentina whole genome sequencing market, by application, 2018 - 2030 (USD Million)
- Table 127 Argentina whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
- Table 128 Middle East & Africa whole genome sequencing market, by country, 2018 - 2030 (USD Million)
- Table 129 Middle East & Africa whole genome sequencing market, by product, 2018 - 2030 (USD Million)
- Table 130 Middle East & Africa whole genome sequencing market, by type, 2018 - 2030 (USD Million)
- Table 131 Middle East & Africa whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
- Table 132 Middle East & Africa whole genome sequencing market, by application, 2018 - 2030 (USD Million)
- Table 133 Middle East & Africa whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
- Table 134 South Africa whole genome sequencing market, by product, 2018 - 2030 (USD Million)
- Table 135 South Africa whole genome sequencing market, by type, 2018 - 2030 (USD Million)
- Table 136 South Africa whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
- Table 137 South Africa whole genome sequencing market, by application, 2018 - 2030 (USD Million)
- Table 138 South Africa whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
- Table 139 Saudi Arabia whole genome sequencing market, by product, 2018 - 2030 (USD Million)
- Table 140 Saudi Arabia whole genome sequencing market, by type, 2018 - 2030 (USD Million)
- Table 141 Saudi Arabia whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
- Table 142 Saudi Arabia whole genome sequencing market, by application, 2018 - 2030 (USD Million)
- Table 143 Saudi Arabia whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
- Table 144 UAE whole genome sequencing market, by product, 2018 - 2030 (USD Million)
- Table 145 UAE whole genome sequencing market, by type, 2018 - 2030 (USD Million)
- Table 146 UAE whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
- Table 147 UAE whole genome sequencing market, by application, 2018 - 2030 (USD Million)
- Table 148 UAE whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
- Table 149 Kuwait whole genome sequencing market, by product, 2018 - 2030 (USD Million)
- Table 150 Kuwait whole genome sequencing market, by type, 2018 - 2030 (USD Million)
- Table 151 Kuwait whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
- Table 152 Kuwait whole genome sequencing market, by application, 2018 - 2030 (USD Million)
- Table 153 Kuwait whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
- Table 154 Participant's overview
- Table 155 Financial performance
- Table 156 Key companies undergoing expansions
- Table 157 Key companies undergoing acquisitions
- Table 158 Key companies undergoing collaborations
- Table 159 Key companies launching new products/services
- Table 160 Key companies undergoing partnerships
- Table 161 Key companies undertaking other strategies
List of Figures
- Fig. 1 Whole genome sequencing market segmentation
- Fig. 2 Market research process
- Fig. 3 Data triangulation techniques
- Fig. 4 Primary research pattern
- Fig. 5 Market research approaches
- Fig. 6 Value-chain-based sizing & forecasting
- Fig. 7 QFD modeling for market share assessment
- Fig. 8 Market formulation & validation
- Fig. 9 Market snapshot
- Fig. 10 Segment snapshot
- Fig. 11 Competitive landscape snapshot
- Fig. 12 Parent market outlook
- Fig. 13 Related/ancillary market outlook
- Fig. 14 Whole genome sequencing - Industry value chain analysis
- Fig. 15 Whole genome sequencing market dynamics
- Fig. 16 Whole genome sequencing market: Porter's analysis
- Fig. 17 Whole genome sequencing market: PESTLE analysis
- Fig. 18 Whole genome sequencing market: Product outlook and key takeaways
- Fig. 19 Whole genome sequencing market: Product market share analysis, 2022 - 2030
- Fig. 20 Global instruments market, 2018 - 2030 (USD Million)
- Fig. 21 Global consumables market, 2018 - 2030 (USD Million)
- Fig. 22 Global services market, 2018 - 2030 (USD Million)
- Fig. 23 Whole genome sequencing market: Type outlook and key takeaways
- Fig. 24 Whole genome sequencing market: Type market share analysis, 2022 - 2030
- Fig. 25 Global large whole genome sequencing market, 2018 - 2030 (USD Million)
- Fig. 26 Global small whole genome sequencing market, 2018 - 2030 (USD Million)
- Fig. 27 Whole genome sequencing market: Workflow outlook and key takeaways
- Fig. 28 Whole genome sequencing market: Workflow market share analysis, 2022 - 2030
- Fig. 29 Global pre-sequencing market, 2018 - 2030 (USD Million)
- Fig. 30 Global sequencing market, 2018 - 2030 (USD Million)
- Fig. 31 Global data analysis market, 2018 - 2030 (USD Million)
- Fig. 32 Whole genome sequencing market: Application outlook and key takeaways
- Fig. 33 Whole genome sequencing market: Application market share analysis, 2022 - 2030
- Fig. 34 Global human whole genome sequencing market, 2018 - 2030 (USD Million)
- Fig. 35 Global plant whole genome sequencing market, 2018 - 2030 (USD Million)
- Fig. 36 Global animal whole genome sequencing market, 2018 - 2030 (USD Million)
- Fig. 37 Global microbial whole genome sequencing market, 2018 - 2030 (USD Million)
- Fig. 38 Whole genome sequencing market: End-use outlook and key takeaways
- Fig. 39 Whole genome sequencing market: End-use market share analysis, 2022 - 2030
- Fig. 40 Global academic & research institutes market, 2018 - 2030 (USD Million)
- Fig. 41 Global hospitals & clinics market, 2018 - 2030 (USD Million)
- Fig. 42 Global pharmaceutical & biotechnology companies market, 2018 - 2030 (USD Million)
- Fig. 43 Global others market, 2018 - 2030 (USD Million)
- Fig. 44 Regional marketplace: Key takeaways
- Fig. 45 Regional marketplace: Key takeaways
- Fig. 46 North America whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 47 U.S. key country dynamics
- Fig. 48 U.S. whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 49 Canada key country dynamics
- Fig. 50 Canada whole genome sequencing market, 2018 - 2030 (USD Million)
- Fig. 51 Europe whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 52 U.K. key country dynamics
- Fig. 53 U.K. whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 54 Germany key country dynamics
- Fig. 55 Germany whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 56 France key country dynamics
- Fig. 57 France whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 58 Italy key country dynamics
- Fig. 59 Italy whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 60 Spain key country dynamics
- Fig. 61 Spain whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 62 Denmark key country dynamics
- Fig. 63 Denmark whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 64 Sweden key country dynamics
- Fig. 65 Sweden whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 66 Norway key country dynamics
- Fig. 67 Norway whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 68 Asia-Pacific whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 69 Japan key country dynamics
- Fig. 70 Japan whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 71 China key country dynamics
- Fig. 72 China whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 73 India key country dynamics
- Fig. 74 India whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 75 Australia key country dynamics
- Fig. 76 Australia whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 77 Thailand key country dynamics
- Fig. 78 Thailand whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 79 South Korea key country dynamics
- Fig. 80 South Korea whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 81 Latin America whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 82 Brazil key country dynamics
- Fig. 83 Brazil whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 84 Mexico key country dynamics
- Fig. 85 Mexico whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 86 Argentina key country dynamics
- Fig. 87 Argentina whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 88 MEA whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 89 South Africa key country dynamics
- Fig. 90 South Africa whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 91 Saudi Arabia key country dynamics
- Fig. 92 Saudi Arabia whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 93 UAE key country dynamics
- Fig. 94 UAE whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 95 Kuwait key country dynamics
- Fig. 96 Kuwait whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 97 Key company categorization
- Fig. 98 Company market positioning
- Fig. 99 Company market share analysis, 2022
- Fig. 100 Market participant categorization
- Fig. 101 Strategy framework
目次
Product Code: GVR-4-68040-037-0
Whole Genome Sequencing Market Growth & Trends:
The global whole genome sequencing market size is projected to reach USD 6.67 billion by 2030, expanding at a CAGR of 20.06% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market growth can be attributed to the rising adoption of whole genome sequencing for genome mapping programs and the increasing prevalence of inherited disorders, including rare genetic disorders. According to the study published in the New England Journal of Medicine in November 2021, whole genome sequencing could lead to the early diagnosis of a wide range of rare diseases and a reported transition to precision medicine.
Furthermore, the growing investment in R&D for the early detection and treatment of disorders with the aid of WGS is expected to propel the growth of the market. For instance, in February 2023, the government of Indonesia and the Genome Science Initiative, with the aid of a USD 30 million investment from the Global Fund, established a network of facilities to perform the method for the early detection and treatment of disorders, including COVID-19, tuberculosis, cancer, genetic disorders, brain diseases, and metabolic disorders.
Whole genome sequencing has a wide range of applications, and government bodies are adopting these technologies for sequencing the genomes of humans, plant, animal, and microbes, which is expected to drive market growth. For instance, U.S. Food & Drug Administration (FDA) adopted the method to identify foodborne pathogens during foodborne disease outbreaks across the countries. The FDA has adopted this technology since 2008 under the Whole Genome Sequencing (WGS) program as it enables it to distinguish all strains of foodborne pathogens more efficiently than pulse-field gel electrophoresis (PFGE).
The rising technological advancements have led to the launch of innovative whole genome sequencing products that offer an affordable, accurate, and timely diagnosis of various diseases and infections. This is contributing to the growth of the market. For instance, in December 2022, LifeCell International Pvt. Ltd. collaborated with HaystackAnalytics to launch TB, a whole genome sequencing test to identify the diagnostic information on tuberculosis infections and tackle the drug resistance challenge.
The COVID-19 pandemic led to an increased demand for the method globally, which enabled the rapid identification of SARS-CoV-2 and the development of possible diagnostic tests to manage the outbreak. Hence, governments across the globe collaborated with research organizations and the corporate sector to use the method to identify and diagnose SARS-CoV-2. Several companies have launched genomic services and rapid solutions for the surveillance of the SARS-CoV-2 virus. For instance, QIAGEN offers the whole genome sequencing services SARS-CoV-2 surveillance for the identification of potent mutants, tracing of possible outbreaks, and advancement of vaccine research and drug development.
Whole Genome Sequencing Market Report Highlights:
- Consumables segment held the largest share of 61.56% in 2022, owing to the availability of a wide range of consumables and increased adoption of these products due to the shorter duration of use of these products
- By type, the large whole genome sequencing segment accounted for the largest share of 77.32% in the whole genome sequencing market in 2022. This can be attributed to the growing applications for analyzing cancerous tumors and identifying genetic variations in rare diseases
- By workflow, the sequencing segment held the largest market share of 52.12% in 2022, owing to the growing involvement of major companies and the launch of novel products to boost the adoption of the process
- By application, the human whole genome sequencing segment dominated the market in 2022 with a share of 62.91%. This can be attributed to the growing prevalence of rare inherited disorders and growing investment in R&D for the method to identify possible causative agents of these disorders
- By end-use, the academic & research institutes segment dominated the global market with the largest share of 48.72%. The large share of the segment can be attributed to the growing demand for high-throughput technologies at these facilities to conduct comprehensive research in this field
- North America held the largest market share of 51.34% in 2022. The large share can be attributed to the presence of a well-established healthcare system and pharmaceutical industry in the region, which has created a significant demand for whole genome sequencing for clinical and research purposes
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Information Procurement
- 1.2. Information or Data Analysis
- 1.3. Market Scope & Segment Definition
- 1.4. Market Model
- 1.4.1. Market Study, By Company Market Share
- 1.4.2. Regional Analysis
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Segmentation and Scope
- 3.2. Market Lineage Outlook
- 3.2.1. Parent Market Outlook
- 3.2.2. Related/Ancillary Market Outlook
- 3.3. Market Dynamics
- 3.3.1. Rising prevalence of inherited disorders
- 3.3.2. Decreasing costs for genetic sequencing
- 3.3.3. Rising demand for whole genome sequencing for genome mapping programs
- 3.4. Market Restraint Analysis
- 3.4.1. Ethical and legal challenges associated with genomic sequencing
- 3.5. Industry Analysis Tools
- 3.5.1. Porter's Five Forces Analysis
- 3.5.2. Macroeconomic Analysis
- 3.6. COVID-19 Impact Analysis
Chapter 4. Whole Genome Sequencing Market: Product Business Analysis
- 4.1. Whole Genome Sequencing Market: Product Market Share Analysis
- 4.2. Whole Genome Sequencing Market Estimates & Forecast, By Product (USD Million)
- 4.3. Instruments
- 4.3.1. Instruments Market, 2018 - 2030 (USD Million)
- 4.4. Consumables
- 4.4.1. Consumables Market, 2018 - 2030 (USD Million)
- 4.5. Services
- 4.5.1. Services Market, 2018 - 2030 (USD Million)
Chapter 5. Whole Genome Sequencing Market: Type Business Analysis
- 5.1. Whole Genome Sequencing Market: Type Market Share Analysis
- 5.2. Whole Genome Sequencing Market Estimates & Forecast, By Type (USD Million)
- 5.3. Large Whole Genome Sequencing
- 5.3.1. Large Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
- 5.4. Small Whole Genome Sequencing
- 5.4.1. Small Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
Chapter 6. Whole Genome Sequencing Market: Workflow Business Analysis
- 6.1. Whole Genome Sequencing Market: Workflow Market Share Analysis
- 6.2. Whole Genome Sequencing Market Estimates & Forecast, By Workflow (USD Million)
- 6.3. Pre-Sequencing
- 6.3.1. Pre-Sequencing Market, 2018 - 2030 (USD Million)
- 6.4. Sequencing
- 6.4.1. Sequencing Market, 2018 - 2030 (USD Million)
- 6.5. Data Analysis
- 6.5.1. Data Analysis Market, 2018 - 2030 (USD Million)
Chapter 7. Whole Genome Sequencing Market: Application Business Analysis
- 7.1. Whole Genome Sequencing Market: Application Market Share Analysis
- 7.2. Whole Genome Sequencing Market Estimates & Forecast, By Application (USD Million)
- 7.3. Human Whole Genome Sequencing
- 7.3.1. Human Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
- 7.4. Plant Whole Exome Sequencing
- 7.4.1. Plant Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
- 7.5. Animal Whole Exome Sequencing
- 7.5.1. Animal Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
- 7.6. Microbial Whole Exome Sequencing
- 7.6.1. Microbial Market, 2018 - 2030 (USD Million)
Chapter 8. Whole Genome Sequencing Market: End-Use Business Analysis
- 8.1. Whole Genome Sequencing Market: End-Use Market Share Analysis
- 8.2. Whole Genome Sequencing Market Estimates & Forecast, By End-Use (USD Million)
- 8.3. Academic & Research Institutes
- 8.3.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
- 8.4. Hospitals & Clinics
- 8.4.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
- 8.5. Pharmaceutical & Biotechnology Companies
- 8.5.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
- 8.6. Others
- 8.6.1. Others Market, 2018 - 2030 (USD Million)
Chapter 9. Whole Genome Sequencing Market: Regional Business Analysis
- 9.1. Whole Genome Sequencing Market Share By Region, 2022 & 2030
- 9.2. North America
- 9.2.1. North America Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
- 9.2.2. U.S.
- 9.2.2.1. Key Country Dynamics
- 9.2.2.2. Target Disease Prevalence
- 9.2.2.3. Competitive Scenario
- 9.2.2.4. Regulatory Framework
- 9.2.2.5. Reimbursement Scenario
- 9.2.2.6. U.S. Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
- 9.2.3. Canada
- 9.2.3.1. Key Country Dynamics
- 9.2.3.2. Target Disease Prevalence
- 9.2.3.3. Competitive Scenario
- 9.2.3.4. Regulatory Framework
- 9.2.3.5. Reimbursement Scenario
- 9.2.3.6. Canada Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
- 9.3. Europe
- 9.3.1. Europe Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
- 9.3.2. Germany
- 9.3.2.1. Key Country Dynamics
- 9.3.2.2. Target Disease Prevalence
- 9.3.2.3. Competitive Scenario
- 9.3.2.4. Regulatory Framework
- 9.3.2.5. Reimbursement Scenario
- 9.3.2.6. Germany Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
- 9.3.3. U.K.
- 9.3.3.1. Key Country Dynamics
- 9.3.3.2. Target Disease Prevalence
- 9.3.3.3. Competitive Scenario
- 9.3.3.4. Regulatory Framework
- 9.3.3.5. Reimbursement Scenario
- 9.3.3.6. U.K. Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
- 9.3.4. France
- 9.3.4.1. Key Country Dynamics
- 9.3.4.2. Target Disease Prevalence
- 9.3.4.3. Competitive Scenario
- 9.3.4.4. Regulatory Framework
- 9.3.4.5. Reimbursement Scenario
- 9.3.4.6. France Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
- 9.3.5. Italy
- 9.3.5.1. Key Country Dynamics
- 9.3.5.2. Target Disease Prevalence
- 9.3.5.3. Competitive Scenario
- 9.3.5.4. Regulatory Framework
- 9.3.5.5. Reimbursement Scenario
- 9.3.5.6. Italy Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
- 9.3.6. Spain
- 9.3.6.1. Key Country Dynamics
- 9.3.6.2. Target Disease Prevalence
- 9.3.6.3. Competitive Scenario
- 9.3.6.4. Regulatory Framework
- 9.3.6.5. Reimbursement Scenario
- 9.3.6.6. Spain Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
- 9.3.7. Denmark
- 9.3.7.1. Key Country Dynamics
- 9.3.7.2. Target Disease Prevalence
- 9.3.7.3. Competitive Scenario
- 9.3.7.4. Regulatory Framework
- 9.3.7.5. Reimbursement Scenario
- 9.3.7.6. Denmark Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
- 9.3.8. Sweden
- 9.3.8.1. Key Country Dynamics
- 9.3.8.2. Target Disease Prevalence
- 9.3.8.3. Competitive Scenario
- 9.3.8.4. Regulatory Framework
- 9.3.8.5. Reimbursement Scenario
- 9.3.8.6. Sweden Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
- 9.3.9. Norway
- 9.3.9.1. Key Country Dynamics
- 9.3.9.2. Target Disease Prevalence
- 9.3.9.3. Competitive Scenario
- 9.3.9.4. Regulatory Framework
- 9.3.9.5. Reimbursement Scenario
- 9.3.9.6. Norway Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
- 9.4. Asia Pacific
- 9.4.1. Asia Pacific Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
- 9.4.2. Japan
- 9.4.2.1. Key Country Dynamics
- 9.4.2.2. Target Disease Prevalence
- 9.4.2.3. Competitive Scenario
- 9.4.2.4. Regulatory Framework
- 9.4.2.5. Reimbursement Scenario
- 9.4.2.6. Japan Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
- 9.4.3. China
- 9.4.3.1. Key Country Dynamics
- 9.4.3.2. Target Disease Prevalence
- 9.4.3.3. Competitive Scenario
- 9.4.3.4. Regulatory Framework
- 9.4.3.5. Reimbursement Scenario
- 9.4.3.6. China Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
- 9.4.4. India
- 9.4.4.1. Key Country Dynamics
- 9.4.4.2. Target Disease Prevalence
- 9.4.4.3. Competitive Scenario
- 9.4.4.4. Regulatory Framework
- 9.4.4.5. Reimbursement Scenario
- 9.4.4.6. India Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
- 9.4.5. South Korea
- 9.4.5.1. Key Country Dynamics
- 9.4.5.2. Target Disease Prevalence
- 9.4.5.3. Competitive Scenario
- 9.4.5.4. Regulatory Framework
- 9.4.5.5. Reimbursement Scenario
- 9.4.5.6. South Korea Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
- 9.4.6. Australia
- 9.4.6.1. Key Country Dynamics
- 9.4.6.2. Target Disease Prevalence
- 9.4.6.3. Competitive Scenario
- 9.4.6.4. Regulatory Framework
- 9.4.6.5. Reimbursement Scenario
- 9.4.6.6. Australia Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
- 9.4.7. Thailand
- 9.4.7.1. Key Country Dynamics
- 9.4.7.2. Target Disease Prevalence
- 9.4.7.3. Competitive Scenario
- 9.4.7.4. Regulatory Framework
- 9.4.7.5. Reimbursement Scenario
- 9.4.7.6. Thailand Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
- 9.5. Latin America
- 9.5.1. Latin America Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
- 9.5.2. Brazil
- 9.5.2.1. Key Country Dynamics
- 9.5.2.2. Target Disease Prevalence
- 9.5.2.3. Competitive Scenario
- 9.5.2.4. Regulatory Framework
- 9.5.2.5. Reimbursement Scenario
- 9.5.2.6. Brazil Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
- 9.5.3. Mexico
- 9.5.3.1. Key Country Dynamics
- 9.5.3.2. Target Disease Prevalence
- 9.5.3.3. Competitive Scenario
- 9.5.3.4. Regulatory Framework
- 9.5.3.5. Reimbursement Scenario
- 9.5.3.6. Mexico Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
- 9.5.4. Argentina
- 9.5.4.1. Key Country Dynamics
- 9.5.4.2. Target Disease Prevalence
- 9.5.4.3. Competitive Scenario
- 9.5.4.4. Regulatory Framework
- 9.5.4.5. Reimbursement Scenario
- 9.5.4.6. Argentina Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
- 9.6. MEA
- 9.6.1. MEA Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
- 9.6.2. South Africa
- 9.6.2.1. Key Country Dynamics
- 9.6.2.2. Target Disease Prevalence
- 9.6.2.3. Competitive Scenario
- 9.6.2.4. Regulatory Framework
- 9.6.2.5. Reimbursement Scenario
- 9.6.2.6. South Africa Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
- 9.6.3. Saudi Arabia
- 9.6.3.1. Key Country Dynamics
- 9.6.3.2. Target Disease Prevalence
- 9.6.3.3. Competitive Scenario
- 9.6.3.4. Regulatory Framework
- 9.6.3.5. Reimbursement Scenario
- 9.6.3.6. Saudi Arabia Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
- 9.6.4. UAE
- 9.6.4.1. Key Country Dynamics
- 9.6.4.2. Target Disease Prevalence
- 9.6.4.3. Competitive Scenario
- 9.6.4.4. Regulatory Framework
- 9.6.4.5. Reimbursement Scenario
- 9.6.4.6. UAE Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
- 9.6.5. Kuwait
- 9.6.5.1. Key Country Dynamics
- 9.6.5.2. Target Disease Prevalence
- 9.6.5.3. Competitive Scenario
- 9.6.5.4. Regulatory Framework
- 9.6.5.5. Reimbursement Scenario
- 9.6.5.6. Kuwait Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
- 10.1. Company Categorization
- 10.2. Company Market Share Analysis, 2022
- 10.3. Strategy Mapping
- 10.4. Company Profiles/Listing
- 10.4.1. Illumina, Inc.
- 10.4.1.1. Overview
- 10.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 10.4.1.3. Product Benchmarking
- 10.4.1.4. Strategic Initiatives
- 10.4.2. Thermo Fisher Scientific, Inc.
- 10.4.2.1. Overview
- 10.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 10.4.2.3. Product Benchmarking
- 10.4.2.4. Strategic Initiatives
- 10.4.3. Oxford Nanopore Technologies
- 10.4.3.1. Overview
- 10.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 10.4.3.3. Product Benchmarking
- 10.4.3.4. Strategic Initiatives
- 10.4.4. Pacific Biosciences of California, Inc.
- 10.4.4.1. Overview
- 10.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 10.4.4.3. Product Benchmarking
- 10.4.4.4. Strategic Initiatives
- 10.4.5. BGI
- 10.4.5.1. Overview
- 10.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 10.4.5.3. Product Benchmarking
- 10.4.5.4. Strategic Initiatives
- 10.4.6. QIAGEN
- 10.4.6.1. Overview
- 10.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 10.4.6.3. Product Benchmarking
- 10.4.6.4. Strategic Initiatives
- 10.4.7. Agilent Technologies
- 10.4.7.1. Overview
- 10.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 10.4.7.3. Product Benchmarking
- 10.4.7.4. Strategic Initiatives
- 10.4.8. ProPhase Labs, Inc. (Nebula Genomics)
- 10.4.8.1. Overview
- 10.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 10.4.8.3. Product Benchmarking
- 10.4.8.4. Strategic Initiatives
- 10.4.9. Psomagen
- 10.4.9.1. Overview
- 10.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 10.4.9.3. Product Benchmarking
- 10.4.9.4. Strategic Initiatives
- 10.4.10. Azenta US, Inc. (GENEWIZ)
- 10.4.10.1. Overview
- 10.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 10.4.10.3. Product Benchmarking
- 10.4.10.4. Strategic Initiatives
- 10.4.1. Illumina, Inc.
